Pharma Redx is latest firm to delist from AIM
Redx chair Dr Jane Griffiths said: “We believe our current market valuation is not reflective of our track record or future potential”
Redx chair Dr Jane Griffiths said: “We believe our current market valuation is not reflective of our track record or future potential”